特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

医薬品原薬 (API) の中国市場:予測と分析 (2018年)

Market for Active Pharmaceutical Ingredients in China - Forecast and Analysis 2018

発行 Aruvian Research 商品コード 910641
出版日 ページ情報 英文 160 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.61円で換算しております。
医薬品原薬 (API) の中国市場:予測と分析 (2018年) Market for Active Pharmaceutical Ingredients in China - Forecast and Analysis 2018
出版日: 2019年09月01日 ページ情報: 英文 160 Pages
概要

中国は世界第2位の医薬品市場として台頭しており、医薬品・バイオテクノロジー部門の成長が最も速い新興市場のひとつです。中国の医薬品原薬 (API) 市場規模は、アジア太平洋地域の中で日本に次いで第2位となっています。2017年においてはアジア太平洋のAPI産業の収益の20%を中国が構成しました。

当レポートでは、中国における医薬品原薬 (API) 市場について調査し、API市場のイントロダクション、世界市場、アジア太平洋市場、および中国市場における分析と予測、主要企業のプロファイルなどを提供しています。

エグゼクティブサマリー

イントロダクション

世界の医薬品原薬 (API) 市場

  • 産業概要
  • 産業収益

アジア太平洋における医薬品原薬 (API) 市場

  • 産業概要
  • 産業収益
  • アジア太平洋におけるAPIの治療用途
  • 産業への影響

中国における医薬品原薬 (API) 市場

  • 産業概要
  • 産業収益

中国におけるAPI市場:産業セグメンテーション

  • 概要
  • 中国におけるバイオテクノロジーAPI市場
  • 中国における合成API市場

主要企業

  • Albemarle Corporation
  • Allergan Plc
  • BASF SE
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Koninklijke DSM N.V.
  • Lonza Group AG
  • Novartis AG
  • Pfizer Inc.
  • Sigma-Aldrich Corporation
  • Teva Pharmaceutical Industries Limited
  • Aurobindo Pharma
  • Cheng Fong Chemical Co. Ltd
  • China Grand Pharmaceutical and Healthcare Holdings Limited
  • China National Pharmaceutical Group (Sinopharm)
  • CSPC Zhongrun Pharmaceutical Co. Ltd. (Hebei Zhongrun)
  • Guangzhou Pharmaceutical Holdings Limited
  • Harbin Pharmaceutical Group
  • Hebei Yuxing Bio-Engineering Co Ltd
  • Medtronic Plc
  • Nanjing Ange Pharmaceutical
  • Shijiazhuang Pharma Group
  • WuXi AppTec, Inc

用語

調査手法

目次

In recent years, China has emerged as the second biggest pharmaceutical market in the world. It is today one of the fastest emerging markets in the pharmaceutical and biotechnology sector globally. A rapidly-ageing population along with a thriving middle class has opened up this market for tremendous opportunities for active pharmaceutical ingredients (APIs) sector. With the Chinese government setting its sights on becoming an important innovator of a variety of pharmaceutical products.

The market for active pharmaceutical ingredients in China is the second largest API market in the entire Asia Pacific region, second only to Japan. In 2017 alone, China accounted for over 20% of the revenues for the Asia Pacific API industry. With many national pharmaceutical companies dominating the domestic pharmaceutical industry, the Chinese market has recently witnessed the entry of many large foreign pharmaceutical companies setting up their plants in the country. However, China faces a major issue with intellectual property rights protection, which has resulted in a low level of market penetration for branded drugs, allowing generics to dominate the domestic market.

With the government determined to tighten regulations governing intellectual property rights, it is expected that the market for APIs in China is going to witness a major boost in the coming years.

Aruvian Research analyzes the market for APIs in China in its research report Market for Active Pharmaceutical Ingredients in China - Forecast and Analysis 2018. The data covered in this report ranges from 2008 till 2020. Let us take a look at what the report focusses on.

The report begins with an introduction to Active Pharmaceutical Ingredients and then moves on to briefly analyze the global market for active pharmaceutical ingredients. We include an overview of the global market for APIs and a look at the global market's revenues.

Section D of the report analyzes the market for active pharmaceutical ingredients in Asia Pacific through an industry overview, industry revenues, and a look at the various therapeutic applications of APIs in the Asia Pacific region. Impacts on the Asia Pacific active pharmaceutical ingredients market are also analyzed.

With section E, we begin our analysis of the market for active pharmaceutical ingredients in China. This section analyzes the industry through basic statistics and industry revenues. Industry segmentation through the biotech segment and the synthetic API market in China is included in the report, along with a forecast of the industry till 2020.

An analysis of the major industry players, both global and domestic, are included in the report. The major players are analyzed through a business segment profile, a look at their major products and services, and a SWOT analysis. The analysis looks at nearly 25 major companies operating in the Chinese API market.

Research methodology for the report concludes this comprehensive report on the market for active pharmaceutical ingredients in China till 2020.

Table of Contents

A. Executive Summary

B. Introduction to Active Pharmaceutical Ingredients

C. Global Market for Active Pharmaceutical Ingredients (APIs)

  • C.1. Industry Overview
  • C.2. Industry Revenues

D. Market for Active Pharmaceutical Ingredients (APIs) in Asia Pacific

  • D.1. Industry Overview
  • D.2. Industry Revenues
  • D.3. Therapeutic Applications of API in Asia Pacific
  • D.4. Impacts on the Industry

E. Market for Active Pharmaceutical Ingredients (APIs) in China

  • E.1. Industry Overview
  • E.2. Industry Revenues

F. API Market in China: Industry Segmentation

  • F.1. Overview
  • F.2. Biotech API Market in China
  • F.3. Synthetic API Market in China

G. Major Industry Players

  • G.1. Albemarle Corporation
    • G.1.1. Business Profile
    • G.1.2. Major Products & Services
    • G.1.3. SWOT Analysis
  • G.2. Allergan Plc
    • G.2.1. Business Profile
    • G.2.2. Major Products & Services
    • G.2.3. SWOT Analysis
  • G.3. BASF SE
    • G.3.1. Business Profile
    • G.3.2. Major Products & Services
    • G.3.3. SWOT Analysis
  • G.4. Boehringer Ingelheim GmbH
    • G.4.1. Business Profile
    • G.4.2. Major Products & Services
    • G.4.3. SWOT Analysis
  • G.5. Bristol-Myers Squibb Company
    • G.5.1. Business Profile
    • G.5.2. Major Products & Services
    • G.5.3. SWOT Analysis
  • G.6. Koninklijke DSM N.V.
    • G.6.1. Business Profile
    • G.6.2. Major Products & Services
    • G.6.3. SWOT Analysis
  • G.7. Lonza Group AG
    • G.7.1. Business Profile
    • G.7.2. Major Products & Services
    • G.7.3. SWOT Analysis
  • G.8. Novartis AG
    • G.8.1. Business Profile
    • G.8.2. Major Products & Services
    • G.8.3. SWOT Analysis
  • G.9. Pfizer Inc.
    • G.9.1. Business Profile
    • G.9.2. Major Products & Services
    • G.9.3. SWOT Analysis
  • G.10. Sigma-Aldrich Corporation
    • G.10.1. Business Profile
    • G.10.2. Major Products & Services
    • G.10.3. SWOT Analysis
  • G.11. Teva Pharmaceutical Industries Limited
    • G.11.1. Business Profile
    • G.11.2. Major Products & Services
    • G.11.3. SWOT Analysis
  • G.12. Aurobindo Pharma
  • G.13. Cheng Fong Chemical Co. Ltd
  • G.14. China Grand Pharmaceutical and Healthcare Holdings Limited
  • G.15. China National Pharmaceutical Group (Sinopharm)
  • G.16. CSPC Zhongrun Pharmaceutical Co. Ltd. (Hebei Zhongrun)
  • G.17. Guangzhou Pharmaceutical Holdings Limited
  • G.18. Harbin Pharmaceutical Group
  • G.19. Hebei Yuxing Bio-Engineering Co Ltd
  • G.20. Medtronic Plc
  • G.21. Nanjing Ange Pharmaceutical
  • G.22. Shijiazhuang Pharma Group
  • G.23. WuXi AppTec, Inc

H. Glossary of Terms

I. Research Methodology

List of Figures

  • Figure 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
  • Figure 2: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
  • Figure 3: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
  • Figure 4: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2008-2020
  • Figure 5: China API Industry Segmentation by Revenues (%), 2008-2020
  • Figure 6: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2008-2020
  • Figure 7: Share of China Biotech API Market by Application Sector (%), 2008-2020
  • Figure 8: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2008-2020
  • Figure 9: Share of the Synthetic API Market in China by Application Sector (%), 2008-2020

List of Tables

  • Table 1: Revenues of the Global Active Pharmaceutical Ingredient (API) Market (in USD Million), 2008-2020
  • Table 2: Revenues of the Active Pharmaceutical Ingredient (API) Market in Asia Pacific (in USD Million), 2008-2020
  • Table 3: Revenue Breakdown of the API Market in Asia Pacific by Therapeutic Applications (%), 2017 & 2020
  • Table 4: Revenues of the Active Pharmaceutical Ingredient (API) Market in China (in USD Million), 2008-2020
  • Table 5: Revenues of the Biotech API Market in China by Application Sector (in USD Million), 2008-2020
  • Table 6: Revenues of the Synthetic API Market in China by Application Sector (in USD Million), 2008-2020